DRM04 for the treatment of primary axillary hyperhidrosis: Primary results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials

https://doi.org/10.1016/j.jaad.2017.04.419Get rights and content

References (0)

Cited by (0)

Commercial support: This study was funded by Dermira, Inc. All costs associated with development of this poster were funded by Dermira, Inc.

View full text